No connection

Search Results

ADTX vs IMCC

ADTX
Aditxt, Inc.
BEARISH
Price
$1.82
Market Cap
$0.4M
Sector
Healthcare
AI Confidence
95%
IMCC
IM Cannabis Corp.
BEARISH
Price
$0.36
Market Cap
$2.2M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
ADTX
--
IMCC
--
Forward P/E
ADTX
-0.16
IMCC
-0.28
P/B Ratio
ADTX
-0.01
IMCC
-0.8
P/S Ratio
ADTX
67.96
IMCC
0.04
EV/EBITDA
ADTX
-0.22
IMCC
-3.49

Profitability

Gross Margin
ADTX
0.0%
IMCC
17.7%
Operating Margin
ADTX
-419870.0%
IMCC
-31.42%
Profit Margin
ADTX
0.0%
IMCC
-20.68%
ROE
ADTX
--
IMCC
--
ROA
ADTX
-61.7%
IMCC
-10.92%

Growth

Revenue Growth
ADTX
-89.1%
IMCC
17.6%
Earnings Growth
ADTX
--
IMCC
--

Financial Health

Debt/Equity
ADTX
--
IMCC
--
Current Ratio
ADTX
0.02
IMCC
0.67
Quick Ratio
ADTX
0.02
IMCC
0.41

Dividends

Dividend Yield
ADTX
--
IMCC
--
Payout Ratio
ADTX
0.0%
IMCC
0.0%

AI Verdict

ADTX BEARISH

ADTX exhibits severe financial distress, reflected in a Piotroski F-Score of 1/9 (indicating weak financial health) and a lack of an Altman Z-Score, which raises significant bankruptcy risk. The company is unprofitable with a negative ROA of -61.70%, a gross margin of 0.00%, and a staggering -419,870.30% operating margin. Revenue has collapsed by 89.10% YoY, and the stock has declined 100% over the past five years. Despite a low price of $1.82, the valuation metrics are nonsensical (e.g., Price/Sales of 67.96, negative P/E), suggesting extreme overvaluation or data failure. The absence of any analyst coverage and negative insider activity further confirm a lack of institutional confidence.

Strengths
Minimal market cap may offer speculative appeal for high-risk investors
Recent quarter showed a slight Q/Q EPS improvement (+6.9%)
One quarter beat earnings estimate (1/4), indicating potential for volatility in results
Risks
Piotroski F-Score of 1/9 indicates extreme financial weakness and poor operational efficiency
Negative ROA (-61.70%) and operating margin (-419,870.30%) signal severe profitability collapse
Revenue declined 89.10% YoY, with inconsistent and erratic earnings surprises (avg -96.38%)
IMCC BEARISH

IMCC exhibits severe financial distress, characterized by a Piotroski F-Score of 4/9 and the absence of a Graham Number or Altman Z-Score due to negative equity (Price/Book: -0.80). While the company has shown recent revenue growth of 17.6% and a series of EPS 'beats,' these are marginal improvements on a foundation of deep losses and negative margins. The catastrophic 5-year price decline of 99.9% and a current ratio of 0.67 indicate a high risk of insolvency and a lack of investor confidence.

Strengths
Positive YoY revenue growth of 17.60%
Recent quarterly EPS beats (3 of last 4 quarters)
Extremely low Price/Sales ratio (0.04)
Risks
Negative equity as indicated by Price/Book of -0.80
Severe liquidity risk with a Current Ratio of 0.67 and Quick Ratio of 0.41
Persistent negative operating margins (-31.42%)

Compare Another Pair

ADTX vs IMCC: Head-to-Head Comparison

This page compares Aditxt, Inc. (ADTX) and IM Cannabis Corp. (IMCC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile